Clinical Applications of DNA Vaccines: Current ProgressFERRARO, Bernadette; MORROW, Matthew P; HUTNICK, Natalie A et al.Clinical infectious diseases. 2011, Vol 53, Num 3, pp 296-302, issn 1058-4838, 7 p.Article

Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine deliveryOH, Yu-Kyoung; KIM, Jong-Pil; TAE SUN HWANG et al.Vaccine. 2001, Vol 19, Num 31, pp 4519-4525, issn 0264-410XConference Paper

International Meeting on Nucleic Acid Vaccines for the Prevention of Infectious DiseasesVaccine. 1997, Vol 15, Num 8, issn 0264-410X, 155 p.Conference Proceedings

DNA vaccines against enteric infectionsHERRMANN, John E.Vaccine. 2006, Vol 24, Num 18, pp 3705-3708, issn 0264-410X, 4 p.Conference Paper

Development of a robust, versatile, and scalable inoculum train for the production of a DNA vaccineOKONKOWSKI, J; KIZER-BENTLEY, L; LISTNER, K et al.Biotechnology progress. 2005, Vol 21, Num 4, pp 1038-1047, issn 8756-7938, 10 p.Article

DNA Vaccines and Intradermal Vaccination by DNA TattooingOOSTERHUIS, K; VAN DEN BERG, J. H; SCHUMACHER, T. N et al.Current Topics in Microbiology and Immunology. 2012, Vol 351, pp 221-250, issn 0070-217X, 30 p.Article

A therapeutic DNA vaccination strategy for autoimmunity and transplantationLI, Alice; JIANFENG CHEN; HATTORI, Masahiro et al.Vaccine. 2010, Vol 28, Num 8, pp 1897-1904, issn 0264-410X, 8 p.Conference Paper

The antifertility effects of DNA vaccine-induced immune responses against uroguanylinJING SUN; XIA, Hong-Fei; YING YANG et al.Vaccine. 2008, Vol 26, Num 29-30, pp 3696-3704, issn 0264-410X, 9 p.Article

DNA vaccines : Recent developments and future possibilitiesLIU, Margaret A; WARREN, Britta; KARLSSON HEDESTAM, Gunilla B et al.Human gene therapy. 2006, Vol 17, Num 11, pp 1051-1061, issn 1043-0342, 11 p.Article

European Union vaccine research: An overviewSAUTTER, Jürgen; OLESEN, Ole F; BRAY, Jeremy et al.Vaccine. 2011, Vol 29, Num 39, pp 6723-6727, issn 0264-410X, 5 p.Conference Paper

Influenza vaccines generated by reverse geneticsSUBBARAO, K; KATZ, J. M.Current Topics in Microbiology and Immunology. 2004, Vol 283, pp 313-342, issn 0070-217X, 30 p.Article

FDA guidance on prophylactic DNA vaccines: Analysis and recommendationsKLINMAN, Dennis M; KLASCHIK, Sven; TROSS, Debra et al.Vaccine. 2010, Vol 28, Num 16, pp 2801-2805, issn 0264-410X, 5 p.Article

Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenzaRUI WU; QUANJIAO CHEN; LIYUN ZHENG et al.Archives of virology. 2009, Vol 154, Num 8, pp 1203-1210, issn 0304-8608, 8 p.Article

Novel prophylactic and therapeutic vaccine against tuberculosisOKADA, Masaji; KITA, Yoko; TALCAO, Kyoko et al.Vaccine. 2009, Vol 27, Num 25-26, pp 3267-3270, issn 0264-410X, 4 p.Conference Paper

Oxidized and reduced mannan mediated MUC1 DNA immunization induce effective anti-tumor responsesCHOON KIT TANG; SHENG, Kuo-Ching; POUNIOTIS, Dodie et al.Vaccine. 2008, Vol 26, Num 31, pp 3827-3834, issn 0264-410X, 8 p.Article

Protective immunity against α-cobratoxin following a single administration of a genetic vaccine encoding a non-toxic cobratoxin variantPERGOLIZZI, Robert G; DRAGOS, Rachel; ROPPER, Alexander E et al.Human gene therapy. 2005, Vol 16, Num 3, pp 292-298, issn 1043-0342, 7 p.Article

Chemical adjuvants for plasmid DNA vaccinesGREENLAND, John R; LETVIN, Norman L.Vaccine. 2007, Vol 25, Num 19, pp 3731-3741, issn 0264-410X, 11 p.Article

DNA vaccines for cancer tooMIN YU; FINN, Olivera J.Cancer immunology and immunotherapy. 2006, Vol 55, Num 2, pp 119-130, issn 0340-7004, 12 p.Article

Protection of flounder against hirame rhabdovirus (HIRRV) with a DNA vaccine containing the glycoprotein geneJI YEON SEO; KIM, Ki-Hong; KIM, Sung-Gu et al.Vaccine. 2006, Vol 24, Num 7, pp 1009-1015, issn 0264-410X, 7 p.Article

Antigen capture ELISA system for henipaviruses using polyclonal antibodies obtained by DNA immunizationKAKU, Yoshihiro; NOGUCHI, Akira; WANG, Lin-Fa et al.Archives of virology. 2012, Vol 157, Num 8, pp 1605-1609, issn 0304-8608, 5 p.Article

Increased Genetic and Phenotypic Stability of a Promising Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate by Reverse GeneticsLUONGO, Cindy; WINTER, Christine C; COLLINS, Peter L et al.Journal of virology. 2012, Vol 86, Num 19, pp 10792-10804, issn 0022-538X, 13 p.Article

Optimization of Electroporation-Enhanced Intradermal Delivery of DNA Vaccine Using a Minimally Invasive Surface DeviceFENG LIN; XUEFEI SHEN; BRODERICK, Kate E et al.Human gene therapy. Part B. Methods (Print). 2012, Vol 23, Num 3, pp 157-168, issn 1946-6536, 12 p.Article

Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccinesLARSEN, Karen Colbjørn; SPENCER, Alexandra J; HILL, Adrian V. S et al.Vaccine. 2009, Vol 27, Num 41, pp 5589-5598, issn 0264-410X, 10 p.Article

Old and new vaccine approachesARNON, Ruth; BEN-YEDIDIA, Tamar.International immunopharmacology. 2003, Vol 3, Num 8, pp 1195-1204, issn 1567-5769, 10 p.Article

Prime-Boost Interval Matters: A Randomized Phase 1 Study to Identify the Minimum Interval Necessary to Observe the H5 DNA Influenza Vaccine Priming EffectLEDGERWOOD, Julie E; ZEPHIR, Kathryn; MASCOLA, John R et al.The Journal of infectious diseases. 2013, Vol 208, Num 3, pp 418-422, issn 0022-1899, 5 p.Article